New analysis shows Asia gaining, due to increased support from both government, industry
The United States’ global share of biomedical research spending fell from 51 percent in 2007 to 45 percent in 2012, while Japan and China saw dramatic increases in research spending.
The research and development spending in the United States dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China increased by $6.4 billion. Overall, Asia’s share of spending grew from 18 percent to 24 percent. Europe held steady at 29 percent.
Prior analyses have suggested the United States’ share of global expenditures were once as high as 80 percent.
Results of this new analysis, conducted by researchers from industry and academia, including both medical researchers and economists, appear in the Jan. 2 New England Journal of Medicine.
“The United States has long been a world leader in driving research and development in the biomedical science. It’s important to maintain that leadership role because biomedical research has a number of long term downstream economic benefits, especially around job creation,” says study author Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology at the University of Michigan Health System.
Despite reductions in funding from the National Institutes of Health, including a 20 percent drop in purchasing power since 2003, the researchers discovered that the United States’ decline was driven almost entirely by reduced investment from industry, not the public sector. This includes support for clinical trials testing potential new therapies.
Jagsi suggests that this may boil down to fewer regulations and less expense to conduct research in Asia – labor costs less, government may be offering subsidies and the research infrastructure is not as bureaucratic as it is in the United States.
“We were surprised the impact of industry funding was that dramatic, but it’s key to note that government funding is equally important to maintain or grow. Research funded through the National Institutes of Health helps scientists understand how diseases work – this will happen slower as NIH funding continues to be cut,” says study author Justin Chakma, a venture capital investor with Thomas, McNerney & Partners in La Jolla, Calif.
Historically, about half of drugs approved by the U.S. Food and Drug Administration had some federal government funding during the course of the research and development.
The authors note the critical need for increased NIH funding coupled with incentives to industry for investing in biomedical research and development here. They call the lack of a coordinated national biomedical R&D strategy “disappointing.”
The Latest on: Research Spending
[google_news title=”” keyword=”Research Spending” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Research Spending
- Hunchbacked model shows what remote workers will look like by 2100, according to researchon April 28, 2024 at 8:09 am
Working from home might seem like a great idea but research shows it's not necessarily doing the best for everyone's health ...
- New Research: AI Poised To Be ‘Greatest Influence’ On The Future Of Advertisingon April 26, 2024 at 4:22 pm
Given AI’s potential to transform industry practices now and in the future, 59% of practitioners view it more favorably than not, new research revealed.
- New Study Shows How Much Extra You’re Spending Thanks To ‘Tipflation’on April 26, 2024 at 1:50 pm
T he pressure is on for Americans to tip at restaurants, and tip well, according to a new survey conducted by Talker Research. In their recent study, the organization surveyed 2,000 people to see just ...
- New Research from Material and NewtonX Reveals Shifts in Digital Ad Spending and Social Media Strategieson April 25, 2024 at 5:50 pm
A new research report conducted by Material and NewtonX, reveals data and insights into the future of advertising.
- Meta sharpens AI focus, boosts research spendingon April 25, 2024 at 1:39 pm
The tech company will focus on efficiency as AI services scale by improving how models run and using open-source improvements.
- Stop the ’emergency spending’ charade alreadyon April 25, 2024 at 7:32 am
Congress moved closer to passing four separate bills with $95 billion in funding for Ukraine, Israel, Indo-Pacific allies and the domestic submarine industrial base.
- AI spending worries cast gloom over Alphabet, Microsofton April 25, 2024 at 2:04 am
Investors appear to be losing patience with Big Tech's prodigious artificial intelligence investments this week after Meta Platforms signaled deeper spending and a long road to profitability.
- Global military spending saw its steepest spike in more than a decade, with the US vastly outspending everyone elseon April 23, 2024 at 6:11 am
Global military spending hit record highs of $2443 billion in 2023, according to the Stockholm International Peace Research Institute, due to wars.
- Ukraine War Helped Push World Military Spending to 35-Year High, Study Sayson April 22, 2024 at 9:20 am
The outlay reached $2.4 trillion last year, a research group found, 6.8 percent up on 2022. Tensions in Asia and the Middle East also contributed.
- Global military spending climbed 7% in 2023 amid conflicts, think-tank SIPRI sayson April 22, 2024 at 12:52 am
Global military expenditure grew 7% to $2.43 trillion in 2023, the steepest annual rise since 2009 as international peace and security deteriorated, a leading think-tank said on Monday, ...
via Bing News